ANNA WNUK: Open Payments
NPI 1740015668 · CLARKS SUMMIT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 121 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $258 · 2025 $1,879
Food & beverage: $1,879
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $351 |
| Lilly USA, LLC | 23 | $318 |
| Novo Nordisk Inc | 19 | $313 |
| AstraZeneca Pharmaceuticals LP | 8 | $146 |
| PFIZER INC. | 5 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Aimmune Therapeutics, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Exact Sciences Corporation | 3 | $55 |
Products named: JARDIANCE, VRAYLAR, Ozempic, MOUNJARO, Rybelsus, AIRSUPRA, UBRELVY, REXULTI.
Industry payments across PA — which companies pay providers there.
